# A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

> clinical trial · VERIFIED · 2026-06-25

Status: COMPLETED · Sponsor: Viridian Therapeutics, Inc. · Condition: Thyroid Eye Disease

- Company: Viridian Therapeutics, Inc.
- Sector: pharma
- Primary source: https://clinicaltrials.gov/study/NCT07155668

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.